Physician profile
Debra Gardner
NPI 1124056957
$1,263.15
in general payments reported to CMS, 2019-2025
14 companies · $190 in 2025
The $190 reported for 2025 was more than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $109 · 2021: $74.27 · 2022: $71.60 · 2023: $307 · 2024: $296 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741 · Long Term Medical Supply Or Device Loan: $51.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.59 |
| Long Term Medical Supply Or Device Loan | $51.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $299.60 | 2019-2024 | |
| Corium, LLC | $225.32 | 2023-2025 | Azstarys |
| Sanofi Pasteur INC. | $154.08 | 2022-2025 | |
| Glaxosmithkline, LLC. | $119.39 | 2019-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $102.34 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $83.36 | 2024-2025 | Flucelvax |
| Sanofi-Aventis U.S. LLC | $65.86 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $59.92 | 2020-2021 | |
| Baxter Healthcare | $51.82 | 2023 | Hillrom - Cp 150 Resting Electrocardiograph |
| Genentech USA, INC. | $36.86 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $19.21 | 2021 | |
| Dermira, INC. | $17.18 | 2019 | |
| Tris Pharma INC | $15.58 | 2020 | |
| Adlon Therapeutics L.P. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.